Polona Pozeg

Dr. Polona Pozeg

orcid

Research Focus & Metrics

Academic Career Length

9Years (2018-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
1 January 2021 in iScience
Verified
Journal Article
Open access
ASAndrea Serino
Andrea Serino
PPPolona Pozeg
Polona Pozeg
FBFosco Bernasconi
Fosco Bernasconi
MSMarco Solcà
Marco Solcà
MHMasayuki Hara
Masayuki Hara
OBOlaf Blanke
Olaf Blanke
Thought insertion (TI) is characterized by the experience that certain thoughts, occurring in one's mind, are not one's own, but the thoughts of somebody else and suggestive of a psychotic disorder. We report a robotics-based method able to investigate the behavioral and subjective mechanisms of TI in healthy participants. We used a robotic device to alter body perception by providing online sensorimotor stimulation, while participants performed cognitive tasks implying source monitoring of mental states attributed to either oneself or another person. Across several experiments, conflicting sensorimotor stimulation reduced the distinction between self- and other-generated thoughts and was, moreover, associated with the experimentally generated feeling of being in the presence of an alien agent and subjective aspects of TI. Introducing a new robotics-based approach that enables the experimental study of the brain mechanisms of TI, these results link TI to predictable self-other shifts in source monitoring and specific sensorimotor processes.

1 August 2024 in Journal of Neurology
Verified
Journal Article
Open access
PDF file
PPPolona Pozeg
Polona Pozeg
JJJane Jöhr
Jane Jöhr
JPJohn O. Prior
John O. Prior
KDKarin Diserens
Karin Diserens
Vincent DunetVincent Dunet
Vincent Dunet
The aim of this prospective, observational cohort study was to investigate and assess diverse neuroimaging biomarkers to predict patients’ neurological recovery after coma. 32 patients (18–76 years, M = 44.8, SD = 17.7) with disorders of consciousness participated in the study. Multimodal neuroimaging data acquired during the patient’s hospitalization were used to derive cortical glucose metabolism (18F-fluorodeoxyglucose positron emission tomography/computed tomography), and structural (diffusion-weighted imaging) and functional connectivity (resting-state functional MRI) indices. The recovery outcome was defined as a continuous composite score constructed from a multivariate neurobehavioral recovery assessment administered upon the discharge from the hospital. Fractional anisotropy-based white matter integrity in the anterior forebrain mesocircuit (r = 0.72, p < .001, 95% CI: 0.87, 0.45), and the functional connectivity between the antagonistic default mode and dorsal attention resting-state networks (r = − 0.74, p < 0.001, 95% CI: − 0.46, − 0.88) strongly correlated with the recovery outcome. The association between the posterior glucose metabolism and the recovery outcome was moderate (r = 0.38, p = 0.040, 95% CI: 0.66, 0.02). Structural (adjusted R2 = 0.84, p = 0.003) or functional connectivity biomarker (adjusted R2 = 0.85, p = 0.001), but not their combination, significantly improved the model fit to predict the recovery compared solely to bedside neurobehavioral evaluation (adjusted R2 = 0.75). The present study elucidates an important role of specific MRI-derived structural and functional connectivity biomarkers in diagnosis and prognosis of recovery after coma and has implications for clinical care of patients with severe brain injury.

1 December 2018 in Investigative Radiology
Verified
Journal Article
Closed access
GMGuillaume P.O. Marie
Guillaume P.O. Marie
PPPolona Pozeg
Polona Pozeg
RMReto A. Meuli
Reto A. Meuli
PMPhilippe Maeder
Philippe Maeder
JFJoachim Forget
Joachim Forget
Objectives: The purpose of the study was to systematically evaluate the precise spatial and temporal pattern of gadolinium-related changes in T1-weighted signal intensity on unenhanced magnetic resonance (MR) images, occurring in the deep brain nuclei of adult patients exposed to at least 10 consecutive doses of gadodiamide. Materials and Methods: In this monocentric retrospective longitudinal study, we analyzed the brain MR images of 30 patients (12 women, 18 men; mean age, 43 ± 11.6 years) acquired between December 1998 and March 2008. We drew the regions of interest in the dentate nucleus, globus pallidus, putamen, pulvinar, ventral posterior nucleus of the thalamus, superior colliculus, substantia nigra, and white matter on unenhanced T1-weighted images. Each region of interest’s mean signal intensity was normalized by the mean intensity of the pons. The normalized signal intensities were measured at the baseline before first gadodiamide administration and at each of 10 successive MR imaging examinations. We used linear mixed effects models to analyze the data. Results: We observed a significant linear increase of signal intensity ratios across 10 successive gadodiamide administrations (all basal nuclei were significant at P < 0.001, except the ventral posterior thalamus, where P < 0.05), with the fastest signal intensity increase in the dentate nucleus (B = 0.010), followed by the globus pallidus (B = 0.0068), putamen (B = 0.0063), pulvinar (B = 0.0062), superior colliculus (B = 0.0057), substantia nigra (B = 0.0034), and ventral posterior nucleus of the thalamus (B = 0.0031). No significant signal increase was observed in the white matter (P > 0.05). Conclusions: Multiple consecutive administration of gadodiamide is associated with an increase in T1-weighted hypersignal on the unenhanced scans, displaying a gradual and nonuniform pattern across different deep brain nuclei, including the ventral posterior thalamus, which was used as a reference tissue in previous studies.

12 May 2026 in Epilepsy Research
Verified
Journal Article
Open access
PPPolona Pozeg
Polona Pozeg
CKChristian M Korff
Christian M Korff
JFJoël Fluss
Joël Fluss
SDSolange Denervaud
Solange Denervaud
JMJohanna Maeder
Johanna Maeder
SLSébastien Lebon
Sébastien Lebon
Epilepsy with myoclonic-atonic seizure (EMAS) is a rare generalized epilepsy in young children associated with various neurodevelopmental and epileptic outcomes. Although conventional brain imaging is usually normal, we previously identified morphometric alterations in the frontal lobes and cerebellum. We here investigated structural connectivity differences between EMAS patients and healthy subjects several years after epilepsy onset and explored their associations with epilepsy severity and cognitive performance. Thirteen EMAS patients (4 females, 5-14 years) and 14 matched controls were included. Patients were classified into three outcome groups (good, intermediate, poor) according to seizure control and behavioral functioning. Individual structural and diffusion data (T1-weighted sequence, multi-shell diffusion MRI) were processed using the FreeSurfer and the Connectome Mapper pipelines. Number of fibers (NoF), fiber density (FD), fractional anisotropy (FA) and apparent diffusivity coefficient (ADC) were used for group comparison and linear regression analyses. Network-based statistics identified a subnetwork encompassing the sensorimotor cortex and brainstem with reduced fiber count and FD in EMAS patients compared with controls. No group differences were observed in FA or ADC, and neither of these measures correlated with the NoF. In contrast, lower NoF and FD were associated with reduced frontal lobe volume (p = 0.002 and p = 0.001, respectively) and with poorer clinical outcomes (p < 0.001). A specific altered cortico-subcortical network including pericentral motor areas and probably reticular formation, was identified in our EMAS sample. This supports the Doose's original hypothesis of a brainstem-cortical network involvement in EMAS. These changes were not explained by differences in FA or ADC but decrease in the NoF. The role of sustained seizure activity, antiseizure medication and genetics remains to be clarified through prospective longitudinal studies.

10 January 2020 in Journal of Magnetic Resonance Imaging
Verified
Journal Article
Closed access
PDF file
JFJoachim Forget
Joachim Forget
PPPolona Pozeg
Polona Pozeg
RMReto A. Meuli
Reto A. Meuli
PMPhilippe Maeder
Philippe Maeder

3 November 2026 in Trauma Care
Verified
Journal Article
Open access
PDF file
EDEtienne Debiolles
Etienne Debiolles
EMErrikos Maslias
Errikos Maslias
PPPolona Pozeg
Polona Pozeg
JJJane Jöhr
Jane Jöhr
VAViviana Aureli
Viviana Aureli
Vincent DunetVincent Dunet
Vincent Dunet
Background/Objectives: To compare the predictive performance of seven previously published MRI-based traumatic axonal injury (TAI) scoring systems for four key outcomes: in-hospital mortality, coma behavioral profile (disorders of consciousness [DoC] vs. clinical cognitive-motor dissociation [cCMD]) at early phase of hospitalization, functional outcome at discharge and functional outcome (Glasgow Outcome Scale Extended [GOSE]) at 6 months from hospital discharge. Methods: The Gentry, Firsching, Abu Hamdeh, Stockholm, Trondheim, Lausanne logistic regression (L-LR) and support vector machine (L-SVM) scores were retrospectively and independently assessed by two board-certified neuroradiologists, from MRI patients with TBI admitted to our single center Acute Neurorehabilitation Unit. Receiver operating characteristic curves and logistic regression analyses adjusted for age, Marshall CT score, and initial Glasgow Coma Score (GCS) were performed. p-value corrected for multiple testing was set <0.007. Results: Of the 107 patients, 91 who underwent CT and MRI were included (median age: 40 [IQR:25–63], 72 males, GCS: 6 [4–8]), 15 died during hospitalization and 17 had DoC. Only the L-LR (OR: 1.38 [1.10–1.74], p = 0.006) and L-SVM (OR: 1.31 [1.08–1.59], p = 0.005) scores significantly predicted in-hospital mortality. The Trondheim score (OR: 2.68 [1.46–4.94], p = 0.002), L-LR (OR:1.30 [1.11–1.51], p = 0.001) and L-SVM (OR: 1.23 [1.09–1.39], p = 0.001) scores significantly predicted the DoC status. The Stockholm grading score (OR: 3.37 [1.53–7.40], p = 0.003), L-LR (OR:1.28 [1.11–1.47], p = 0.001) and L-SVM (OR: 1.15 [1.05–1.26], p = 0.002) scores were significantly related to poor functional outcome at 6 months. Conclusions: Both Lausanne scores were the only models significantly associated with in-hospital mortality, DoC phenotype classification, and functional outcome at discharge and at 6 months after TBI.